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CHAPTER 1
Reflections on Twenty-Five Years
of Annexin Research
Carl E. Creutz
Abstract
T
his is a personal account of the discovery of synexin (annexin VII) in 1977, along with
some selected observations on the development of the annexin field since that time.
Introduction
The development of research in the annexin field cannot be compared to the growth of a
magnificent tree with a deep taproot traceable to a single origin. Studies of annexins arose in so
many different contexts independently that a better metaphor might be a complex prairie
biome containing multiple plants with independent roots. My objective here is to describe the
origins of my own particular corner of this prairie. I will also describe what I saw as major
developments in other corners of the annexin prairie over time, although I must make it clear
at the outset that my own vision was often obscured by the interesting flora close at hand. I will
comment on certain questions that have arisen in the annexin field that have particularly
fascinated me and that I hope will be resolved in the near future. However, to review in detail
twenty-five years of annexin research would be a Herculean task. Indeed, just to review the
reviews that have been written on annexins would be challenging: Limiting a Medline search
on annexins to the publication type “Review” still yields 251 references. For a more
comprehensive view of the development of this field than I can give here, the reader is strongly
encouraged to consult some of the more extensive reviews that have been written by contributors
from a number of different viewpoints (refs. 1 to 39).
Twenty-five years is a long time in modern science. As the annexin field has developed so
has all of biomedical science. To adequately describe the origins of the annexin field it is helpful
to remember the context in which they occurred, one much poorer in terms of technology and
basic knowledge than we work in today. Technically, the biochemistry laboratory of the middle
to late 70’s did not have many of its now familiar tools. Glass micropipets operated by mouth
were just beginning to be displaced by digital Pipetmen. Fraction collectors were balky and
often allowed precious protein samples to pool on the cold room floor. The model L Spinco
preparative ultracentrifuge was available; the Eppendorf microfuge was not. DNA could not be
sequenced, although small peptides could be, given massive quantities. To do a “proteomics”
experiment was to run an SDS gel on a homemade apparatus and count the bands. Vacuum
tubes were becoming a rarity, although frugal labs often had a few, such as the ones that amplified
the first light scattering signals detecting membrane aggregation by an annexin. The IBM PC
had not been introduced; the first annexin manuscript was drafted in longhand.Annexins 2
In terms of our knowledge base, although it may seem somewhat primitive now, the
middle seventies were an extraordinarily exciting time as the field of molecular cell biology was
just emerging. Membranes had begun to be recognized as “fluid mosaic” structures in which
proteins lumbered while lipids ran circles around them. Cytoplasm was no longer a soup, but
a structured and dynamic milieu infused with filaments of a remarkable colchicine-binding
protein that formed tubules. It was proposed, heretically, that the muscle proteins actin and
myosin might play broader roles underlying movements within cells of all types. Calcium
bound to EF hands to promote stimulus-response coupling. In muscle these hands were found
in troponin C. Elsewhere, most calcium stimulated events were assumed to be triggered by the
binding of calcium to the newly discovered transducer, calmodulin.
As a biophysics graduate student at Johns Hopkins University in the middle 70’s I became
interested in the problem of exocytosis. Here, I felt, was a problem which in its solution would
require delving into three emerging subjects—membrane structure, cytoplasmic movements,
and calcium signalling. As exocytosis was, beyond its morphological definition, a complete
“black box”, this problem seemed to promise to provide sufficient entertainment for a long
career. Of the many pipe dreams I have had about exocytosis, in this, at least, I think I was
correct.
Synexin
In 1976 I joined Harvey Pollard’s laboratory at the NIH, having just completed a Ph.D.
thesis in which I demonstrated the existence of myosin in the adrenal medulla.40 Harvey and I
tried at first to “shoehorn” the process of exocytosis into the actin-myosin paradigm by testing
whether these proteins would influence the stability of isolated chromaffin granules. When this
failed we turned instead to the classic “grind and find” approach of the biochemist. We
hypothesized that there might be calcium-regulated factors in adrenal medullary cytosol that
would promote release of catecholamines from isolated chromaffin granules. We did find that
chromaffin granules that had not been extensively washed, as was normally done during their
isolation, seemed vaguely aware of calcium in the rate in which they would undergo chemiosmotic
bursting in the presence of ATP and Cl-. This was not a consistent result, in either its magnitude
or direction. In search of a clearer result, I was soon performing hundreds of catecholamine
release assays on crude granule preparations. Often these preparations consisted of little more
than post nuclear supernatants desalted overnight in the coldroom on a G-25 column the size
of a bazooka. We rationalized that by going to these very crude preparations we would be
including any other factors, such as the plasma membrane, that might be needed to reconstitute
the exocytosis process.
In due time I found the catecholamine assays an arduous way to obtain kinetic data on
small changes in catecholamine release rates from these homogenates. I decided to try monitoring
the turbidity of the preparations. In this I was inspired by work in the mitochondrial field: The
chemiosmotic swelling of mitochondria could be detected by monitoring the associated decrease
in absorbance of mitochondrial suspensions at 540 nm. I found that the same measurement
provided a reliable indicator of the loss of catecholamines from the dense core chromaffin
granules in the homogenates. This change in technical approach is what first brought an annexin
into our sights: Surprisingly, calcium decreased the rate of decline of turbidity of the homogenates.
This was not what we had hoped for, because it suggested calcium was acting to suppress,
rather than accelerate the release of the catecholamine. Even more unexpected was the observation
that sometimes the turbidity of the homogenate increased in a calcium-dependent manner.
This did not fit any expected paradigm; something we didn’t understand was happening. Were
the granules shrinking instead of swelling? By separating the homogenate into soluble and
particulate fractions we soon found that the soluble fraction contained a factor that would3 Reflections on Twenty-Five Years of Annexin Research
cause an increase in turbidity of a washed particulate fraction, or even of preparations of isolated
chromaffin granules (Fig. 1).
It was not until I examined these preparations in a phase microscope that I realized what
is now so obvious—the chromaffin granules were clumping together and this led to an increase
in the turbidity of the suspension. It immediately occurred to us that this calcium-regulated
cytosolic factor might play a pivotal role in exocytosis—that of bringing two membranes together
to promote membrane fusion. Our experiments with isolated granules could only reflect possible
granule-granule interactions during compound exocytosis, but there seemed no reason not to
propose that the same factor might also promote contacts between granule membranes and the
plasma membrane. Indeed, it is possible the plasma membrane was participating in the process
in the case of the crude homogenates, but we had no easy way to sort this out. Because of the
ability of this factor to promote meetings between membranes, we named it synexin, from the
Greek synexis, which means “a meeting”.41 (This replaced the unfortunate term “humpin” that
we initially used to refer to the factor in the cytosol that caused the “hump” in the turbidity
traces – as seen in Fig.1). The turbidity assay using isolated chromaffin granules proved a
convenient way to monitor the purification of the protein, now also referred to as annexin VII,
from adrenal medullary cytosol. It would be convenient to say now that we were clever enough
to think up this nice “biochemical” assay for an event central to exocytosis and then to go after
proteins active in the assay. But it would not be the truth.
I have often wondered why we stumbled upon only synexin in these early experiments
when there was a whole family of annexins waiting in that cytosol to be discovered. I believe
that the activities of some annexins were cancelled out by others—for example annexins V and
VI bind to membranes but don’t aggregate them so they can interfere with the aggregating
activity of other annexins. The weak aggregating activity of the crude cytosol was presumably
the result of the sum of the actions of aggregating and inhibitory annexins. The first step in our
isolation method involved ammonium sulfate precipitation. Synexin behaved anomolously in
this step, precipitating at less than 20% saturation of ammonium sulfate whereas the other
annexins remained in the higher cuts. It was easy to assume that the large increase in activity
found in the first cut represented the totality of the aggregating activity. I had to defocus a little,
a few years later, before encountering other members of the annexin family.
Membrane Fusion
Electron microscopic examination of the contacts formed between chromaffin granules
by synexin made it clear that synexin was not a fusogenic protein per se—it promoted only the
close attachment of membranes to one another. A series of careful studies from Demetrious
Papahajopoulos’ laboratory indicated that pure lipid vesicles of certain compositions would
fuse in response to synexin action, but these were lipids that tended to be fusogenic on their
own. The action of synexin was only to accelerate the initial aggregation step but not the
kinetics of the fusion step.28,42 The chromaffin granules were resistant to this fusion step. Inspired
by Alan Finkelstein’s observations on the role of intravesicular osmotic pressure in promoting
lipid vesicle-planar bilayer fusion,43 we tried “pumping up” the attached granules by providing
ATP and permeant anions. However, this resulted in the granule membranes bursting everywhere
except where they were attached to one another by synexin. The membrane contacts formed by
synexin were apparently especially stable structures, not what one would expect if they represented
a precursor state to membrane fusion.
It was clear that if synexin initiated membrane contacts in exocytosis, something else then
had to happen to promote membrane fusion. Shortly thereafter we were able to propose that
one additional factor might be sufficient: Free arachidonic acid. This fusogenic lipid is released
in stimulated cells through the action of calcium-activated phospholipase A2, so there seemedAnnexins 4
a good rationale to suggest it might play a role. But we proposed this only after stumbling on
the fusogenic activity of arachidonic acid in vitro in a rather indirect way.
I happened to use synexin to prepare large clumps of very pure (gradient purified)
chromaffin granules. I wanted to see just how big the clumps were so I looked at them in the
phase microscope. As I watched the clumps over a period of a few minutes I was astounded to
see the granules start to fuse together, eventually forming large bubble-like structures up to 10
µm across. Although this was thrilling to watch, what was vexing was that the chromaffin
granules would fuse only when I was watching them. They could sit in a test tube all afternoon
Figure 1. An early indication of annexin activity. In this experiment, performed on February 3, 1977,
“crude” chromaffin granules were incubated with a 0 to 20% ammonium sulfate cut from adrenal medullary
cytosol. The traces on this section of chart paper represent the turbidities of four different sample cuvettes
measured at 540 nm as a function of time. Each cuvette was sampled every 60 seconds. The independent
variable in this experiment was the free calcium concentration which was set at 0.01 µM, 1 µM, 100 µM,
5000 µM, from bottom to top. The bottom trace indicates that the turbidity of the granule suspension
declines with time as the granules undergo chemiosmotic bursting. In the upper traces this decline is masked
due to a calcium-dependent increase in turbidity associated with granule aggregation caused by synexin
(annexin VII) in the cytosol fraction.5 Reflections on Twenty-Five Years of Annexin Research
and do nothing, kindly waiting for me to take a look before they started to fuse. Was it light?
Was it the warm microscope stage? Was it pressure from the cover slip? In fact, we traced the
cause to contaminants on the microscope slide. A simple cleansing of the slide with ethanol
prevented the fusion event completely. As we soon learned, microscope slides are treated with
surfactants so that they do not have drying spots on them—just as we use surfactants in our
automatic dishwashers so our crystal glassware does not have embarrassing spots. Calls to slide
manufacturers were not helpful in identifying the factor since the surfactants used are a trade
secret. However, we learned that some industrial surfactant preparations are derived from
slaughterhouse waste and this set us to thinking about natural lipids as a source of the fusogen.
The first compound I tested for chromaffin granule fusogenic activity was arachidonic acid,
and it worked the best. The structure-activity relationship indicated that the fatty acid had to
be of typical length for a membrane fatty acid, had to have at least one double bond, and had
to have a free, unesterified head group. Arachidonic acid fit the bill perfectly in terms of the in
vitro activity as well as the biological context.44
The activities of synexin in vitro thus allowed us to propose a minimal model for calcium
regulated membrane fusion in exocytosis: Calcium causes synexin to form contacts between
relevant membranes, then release of arachidonic acid would cause the membrane contacts to
fuse. Although the model seems simplistic now, it was a decade before this “synexin hypothesis
for exocytosis” had to yield center stage to the profoundly important SNARE hypothesis and
the veritable stew of C2-domain containing proteins that have since been discovered in the
synapse. Ironically, one factor that prevented the synexin hypothesis from gaining wider
acceptance when it was introduced was the apparently low sensitivity of synexin for calcium.
Half-maximal chromaffin granule aggregation occurred only at 200 µM calcium, while other
cytoplasmic sensors for calcium, such as calmodulin, were activated by micromolar levels of
calcium or less. It was a little too late when the paradigm later shifted, and the “low affinity
calcium sensor” became the “holy grail” in the exocytosis field as calcium levels near sites of
exocytosis were recognized to approach hundreds of micromolar.
However, I think the actual calcium sensitivity of annexins remains a thorny issue. Since
the binding of calcium was later found to require participation of the lipid headgroups of the
membrane that is binding the annexin, the lipid composition of the membrane, or of domains
of the membrane, can influence the observed calcium sensitivity.45 Furthermore, as discovered
later, different annexins have different calcium sensitivities. Of particular importance, the annexin
II tetramer was found to aggregate chromaffin granules at 1 or 2 µM free calcium.46 We proposed
the mechanism of membrane aggregation by annexins involves an attachment step, during
which the annexin binds a single membrane, which can be stimulated at low levels of calcium,
and then an annexin self-association step that occurs at higher levels of calcium bringing two
membranes together.47 The annexin II tetramer is already self-associated in a sense, so its calcium
sensitivity reflected the original membrane contact step. Given the number of annexins in cells
as well as the possible effects of local membrane environment on their calcium sensitivities, it
no longer seems possible to rule in or out a role for annexins in a given cellular process based
solely on the apparent calcium sensitivity of the process.
It remains an interesting question why the membrane contacts formed by annexins between
chromaffin granules are particularly susceptible to fusion in the presence of arachidonic acid.
Arachidonic acid is, in physical-chemical terms, nothing more than a detergent so it is not
surprising it can disrupt membrane structure. Certainly, we found that high concentrations
would completely dissolve chromaffin granules. However, when present at physiologically
relevant amounts—which we calculated to be on the order of 2 mole percent relative to
membrane lipids—the action of arachidonic acid was very specific to the location where two
membranes were tacked together by synexin. The molecular structure of these junctions would
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they do not form at low temperature (0 to 4oC), and they are irreversible (stable to the chelation
of calcium). We continue to speculate that these junctions may be particularly susceptible to
the action of fusogenic protein complexes such as the SNARE complex. In this way the annexins
continue to hold, in my mind, a hypothetical role in contributing to the overall process of
exocytosis or membrane fusion events elsewhere in the cell.
A Protein Family Emerges
As mentioned above, it took some time before the breadth of the annexin family of proteins
was recognized. In 1981 I moved to the University of Virginia. An attractive feature of this new
environment was the presence of strong research efforts in calcium-binding proteins (Robert
Kretsinger), organelle movements (Lenny Rebhun), and membrane structure (Tom Thompson
and Rod Biltonen), all areas of research that seemed important for understanding exocytosis.
In addition, I felt the Pharmacology Department was an appropriate home for me because
much of the historical work on chromaffin granules had been done by pharmacologists, and
the Chairman of Pharmacology, Joseph Larner, had a compelling vision of the importance of
interdisciplinary basic research to the development of pharmacology.
In Charlottesville I followed up preliminary experiments I had initiated at the NIH to
address whether synexin was an unusual or unique protein in its ability to associate in a calcium-
dependent fashion with chromaffin granule membranes. Indeed, it turned out synexin was just
the tip of the iceberg. We applied soluble adrenal medullary extracts to an affinity column of
chromaffin granule membranes bound to Sepharose 4B in the presence of high concentrations
of calcium, and then eluted calcium-dependent, membrane-binding proteins by washing the
column with EGTA. Synexin was obtained in these experiments, but as a minor component of
a complex array of 23 spots on two-dimensional gels. We named these proteins chromobindins,48
in analogy with the established terms for the proteins in the granule, the chromogranins, and
the proteins in the granule membrane, the chromomembrins. Many of these chromaffin granule-
binding proteins were being studied simultaneously by Michael Geisow and Robert Burgoyne
at the NIMR at Mill Hill in London using centrifugation rather than affinity chromatography
to isolate them.49 We  envisioned that these proteins could act to change the character of
membrane surfaces in stimulated cells when calcium levels are increased. In this way they could
be involved in a number of processes including membrane fusion, membrane-cytoskeletal
contacts, and organization of lipids and proteins in the membrane to form signalling complexes.
However, at the time we had no idea that many of these proteins would turn out to be homologs
of synexin.
At about the same time John Dedman’s group at the University of Texas was performing a
series of analogous experiments. In this case, Dedman wished to address whether calmodulin
was a unique or unusual protein or whether there might be many other mediators of the calcium
signal within cells. Using affinity chromatography on columns of phenothiazines, known to
bind calmodulin in a calcium-dependent manner, they established that there were a number of
proteins that behaved similarly. They called these proteins calcimedins because of their presumed
role in mediating the actions of calcium.50 Whether these proteins were binding the
phenothiazine directly or were binding lipids that bound to the column seems unclear, but in
any event, the majority of these proteins were the same ones we found interacting with chromaffin
granule membranes.
At a similar point in time Volker Gerke, Klaus Weber, and colleagues at the Planck Institute
in Goettingen were dissecting the components of the cytoskeleton-rich brush border of intestinal
epithelial cells. This fascinating structure performs complex dances under the apparent regulation
of calcium and thus promised to be a source of calcium-regulated proteins that might control
cytoskeletal function. Prominent calcium-binding proteins were found in these extracts of7 Reflections on Twenty-Five Years of Annexin Research
molecular weights around 32 and 68 kDa.51 Unknown at the time, they were some of the same
proteins under study in Charlottesville, Mill Hill, and Houston. In another corner of the Planck
Institute in Goettingen a prominent calcium and membrane binding protein was also discovered
during this period by John Walker, Thomas Sudhof, and colleagues during their studies of the
classical synaptic model tissue, the electroplaques of Torpedo marmorata. Calcium and electricity
led to the name calelectrin, and mammalian proteins with similar properties were similarly
named.52,53
One might have guessed there would turn out to be strong similarities between these
proteins under study that interacted with calcium and membranes, but at the time the
connections were not clear. Even less obvious was that two prominent substrates for
phosphorylation by tyrosine kinases also were related proteins. Stanley Cohen’s laboratory was
characterizing a 35 kDa substrate for the EGF receptor tyrosine kinase activity, 54 and a number
of investigators, beginning with Radke and Martin, were interested in a major 36 kDa substrate
for the src kinase.55 It was also not recognized that anti-inflammatory mediators under study in
Flower’s group,56 Axelrod’s group,57 or Russo-Marie’s group58 would fall into this same class.
Anticoagulant proteins from the placenta were also less obviously related.59-61
Although antibody cross-reactions between some of these proteins had been suggestive,
the veil was not lifted to reveal the extent of interconnections between these lines of research
until protein sequence data was obtained proving direct links between members of this emerging
protein family. A watershed event was the publication in 1986 by Geisow and colleagues of
peptide sequence data indicating the presence in some of these proteins of a repeating
characteristic sequence that was unrelated to that of known calcium-binding proteins.62 This
“endonexin fold”63 sequence was found in endonexin (annexin IV), p36 (annexin II), and
Torpedo calelectrin. In the same year, Saris, Kristoff, Glenney, Hunter and colleagues in San
Diego reported the full length sequence of p36 (annexin II)64,65 and Wallner, Pepinsky and
colleagues at Biogen in Massachussetts reported the sequence of lipocortin (annexin I).66 Both
of these sequences revealed the presence of multiple copies of the endonexin fold.
Ironically, synexin was a bit slower to join the group. In our own efforts to obtain sequence
data for synexin, we were only able to come up with peptides derived from the long, unique,
repeating, N-terminal domain of this protein, which was presumably extended and more readily
cleaved by proteases than the annexin core.67 Bob Kretsinger and I spent some time puzzling
over repeating tyrosines, prolines and glycines to see if we could design a novel calcium binding
site. Later on we published with Norio Matsushima a set of models of repeating “pro-beta”
helices (polyproline, beta-turn helices) that such sequences in a number of proteins might
form.68 But this turned out to be a distraction from the major point to be learned from the full
synexin sequence. This was finally obtained by Pollard’s group, revealing that synexin indeed fit
into the annexin family.69
The coalescence of the annexin field from many different backgrounds led quickly to a
confusing “tangle of terminology”70 (Fig. 2).71 It has been said that molecular biologists would
sooner use one another’s tooth brushes than use one another’s names for new proteins. Fortunately
the name “annexin”, suggested by Michael Geisow,72 seemed a good compromise while retaining
some of the character of the original “synexin”. A birth announcement for the new name was
posted in Nature in 1990 by John Dedman and Michael Crumpton.70
Many people working on annexins at that time may have had a similar reaction to my
own. Suddenly we were not alone. It was apparent there were many people around the world
who had similar interests. I found it invigorating to have the company, but I also had to ask, as
new vistas opened to me, have I been on the wrong track? What process are the proteins “really”
responsible for? Of course this question continues to plague the field, although the answer is
likely to be that these abundant proteins are involved in many processes, some of which we
visualized and some we did not. It is possible that I have the distinction of being the first personAnnexins 8
to have a grant application to study annexins turned down because I didn’t know the “real”
physiological function of these proteins. If so, I imagine many others have followed me down
this ignominious path. Ironically, I think it was the wealth of information about the different
processes that could be regulated by annexins that led to this “identity crisis” in the field. I
think now we should embrace this diversity as one of the strengths of the field. It likely reflects
the true nature of the roles of these multifaceted proteins in biology.
Annexin Sequences
The annexin amino acid sequences were intrinsically interesting because they were
completely novel. To the surprise and discomfit of some, there was no EF hand. With Bob
Kretsinger, who discovered the EF hand,73 looking over my shoulder, this hit a little close to
home. Fortunately, he has always been gracious about it. This novelty led to a degree of reluctance,
in some parts, to accept the annexins as “real” calcium binding proteins. However, this is not an
Figure 2. Sequence data provided the “Rosetta stone” that allowed integration of the annexin field. This
cartoon accompanied a review on annexins by Hollenberg, Valentine-Braun, and Northup published in
Trends in the Pharmacological Sciences in 1988.71 Reprinted with permission from Elsevier Science.9 Reflections on Twenty-Five Years of Annexin Research
issue that I need to debate. Evolution has already provided the answer: The amino acids that
coordinate calcium in annexin crystal structures are among the most highly conserved.
As sequence data continued to accumulate in the 1980s and 90s, the diversity of the
known annexin family grew. It became apparent that not only had annexins radiated into a
diverse family of proteins in a given organism, but they were present in a wide range of our
fellow travelers on the planet, including insects, nematodes, protists, plants, slime molds, and
fungi. The curious exception has been the yeast Saccharomyces. I have always found it a challenging
puzzle to guess what function served by annexins is so fundamental as to be found in both
plants and animals but not so fundamental as to be indispensable in yeast. I do not think there
are many examples of such proteins, although this same puzzle has come back to haunt me in
our more recent studies of another family of calcium-dependent, membrane-binding proteins,
the copines.74
Although we can now associate many parts of the annexin amino acid sequences with
specific functions such as binding calcium or lipids, the curious CGGDD motif, along with its
minor variations, at the C-terminus of most mammalian sequences remains an enigma. C-
terminal motifs in other proteins often play important functional or signalling roles. The cysteine-
containing motifs on small G proteins are sites of lipid modification essential to function. The
KDEL motif of luminal proteins of the endoplasmic reticulum assures their proper retention
in this organelle. Is the annexin C terminal cysteine motif a site for modification, or is it
involved in localization? And why is the motif not important in, for example, plants or
nematodes? Expression studies of mutant annexins with modifications in this motif might
provide important insights into this puzzle.
Annexin Phosphorylation
An important theme in the annexin field has been the ability of a number of annexins to
be phosphorylated. We had determined that chromobindins 9 and 8 are phosphoproteins before
the important integration of the annexin field occurred in the 1980s and revealed that we had
been working with annexins I and II, respectively.75,76 These proteins, also called lipocortin
and calpactin, had established reputations as important, “professional” phosphoproteins since
they were the best known substrates of the EGF receptor kinase and the src kinase, respectively.
At the time, tyrosine phosphorylation had just gained recognition as a critical signalling process
in the regulation of cell growth and the conversion to malignancy. There was intense interest in
identifying the substrates of tyrosine kinases and determining the functions of these substrates.
At least in the case of the annexins, identification was the easy part; relating the functions of the
annexins to cell growth control has remained challenging. I have felt strongly that study of
annexin phosphorylation can be important in determining the biological functions of annexins.
The phosphorylation sites show a high degree of conservation in the annexin family, so it seems
safe to assume that the activities that are regulated by phosphorylation are physiologically
important. Since annexins can be made to perform many tricks in vitro, identifying which
trick is modulated by phosphorylation may bring us closer to identifying a physiologically
relevant activity. Evidence that binding calcium and membranes is physiologically important
seems solid because the residues involved in these activities are also highly conserved. However,
the general theme that has become apparent is that phosphorylation has only a modest influence
on these processes per se. Rather, phosphorylation has a greater effect on the “bivalent” activity
of the annexins—the ability to aggregate membranes. In the case of annexins I and II,
phosphorylation inhibits this activity,77,78 in the case of annexin VII79 it enhances it. I think
that this is suggestive that the bivalent activity of annexins has biological relevance and is not
merely an in vitro artifact. Phosphorylation also “opens up” the N-terminal domains of annexins,
making them more susceptible to proteolysis, which in turn alters their calcium sensitivity.80,81Annexins 10
Therefore, proteolysis may be physiologically important in providing irreversible regulation of
annexin activity. Phosphorylation may also influence the ability of annexin II to enter the
nucleus;82 therefore, although we don’t know why annexin II travels there, its voyage into the
nucleus is likely to be physiologically important.
Annexins In and Out of Cells
The coalescence of the annexin field from many different areas of investigation created
some odd bedfellows: Investigators studying proteins inside the cell became newly intimate
with those studying phenomena outside of cells. Could the same proteins perform both
intracellular and extracellular functions? How could these manifestly cytoplasmic proteins get
outside of cells to inhibit blood coagulation, promote thrombin formation, bind to collagen,
block inflammation, and do whatever it is they do in seminal fluid?83 The release of annexins
from matrix vesicles during bone formation suggests a model for the escape mechanism: Blebs
may “pinch off” from the plasma membrane and then break down to release their content.84
Perhaps the annexins themselves could provide the “pinch”. At first blush this type of “apocrine”
annexin secretion might seem like a nonselective and wasteful process. However, if the formation
of the released vesicle involves calcium signalling, annexins might naturally become enriched
in these vesicles before they are pinched off, increasing the selectivity of the process. It seems
unlikely that such a process would occur in single celled organisms, but in the context of
multicellular organisms it now seems quite plausible, and well supported, that the annexins can
play regulatory and signalling roles, as well as structural roles, outside of cells.
Also unexpected, to me at least, have been repeated observations that the presumably
cytosolic annexins can turn the other way and enter the nucleus. This has been particularly well
documented in the immunofluorescence studies of John Walker’s group on annexin V,85 and
Hidaka’s group on annexin XI,86 and more recently by Eberhard’s studies on annexin II.82
These observations may be a reflection of the early work of Vishwanatha who reported a DNA
replication promoting activity of annexin II.87 More recently Anni Vedeler has identified annexin
II in cytosolic, mRNA-containing polysomes.88 Was the annexin involved in escorting the
mRNA from the nucleus? Recent reports suggest annexin VII can function as a tumor
suppressor.89,90 Does it accomplish this by travelling into the nucleus and affecting gene
expression? Or might it signal to the nucleus through the actions of the annexin VII-binding
protein sorcin?91 The close homolog of sorcin, ALG2 has been implicated in apoptotic processes
that may also involve nuclear signalling.92 It now seems quite credible to hypothesize that
annexins carry information about activities in the cytoplasm or on the surface membrane into
the nucleus to stimulate DNA synthetic or RNA transcriptional, splicing, or transport responses.
The signalling process might require calcium, but also, in the case of annexin II, could involve
tyrosine phosphorylation by cell surface receptors or receptor-associated kinases.
Annexin Structure
The annexin field received a revitalizing jolt when Robert Huber and his colleagues
published the first annexin crystal structure in 1990.93,94 To have a structural biologist of Huber’s
stature become interested in annexins was real boost for all of us in the field. But it might not
have happened. As Huber revealed to me one evening over a relaxing dinner in Charlottesville,
he incorporated the annexins into his program of research on proteases. Within this program
he has been studying the complementary structures of protease inhibitors as well as proteases.
When he heard of a new class of anticoagulants recently discovered in placenta he guessed that,
like other anticoagulants that block proteases in the coagulation cascade, these proteins would
be protease inhibitors. Determining the structure of one of these anticoagulants, annexin V,
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one look at the structure made him immediately suspect the annexins were not protease
inhibitors. It was then that he read the paper by Pollard and Rojas95 indicating that annexins
can promote ion permeation through membranes. The parallel bundles of alpha helices with
the hole in the center that he had visualized for the first time were much more suggestive of an
ion channel than a protease inhibitor.
One wonders to what extent progress in our field might have been delayed if Huber had
instead asked a student or postdoc to take on the annexin project. Would he or she have begun
with a more thorough reading of the background literature, found that annexins are lipid-
binding proteins and not protease inhibitors, and brought the project to a halt before it started?
Perhaps the delay would not have been great, as there were independent efforts to determine
the structures of annexins in other labs which shortly afterwards came to fruition.96,97 However,
at least in our case, the availability of Huber’s coordinates for use in molecular replacement
analyses certainly paved the way.98,99
The structure of annexin V, which turned out to be a valid prototype for other annexins,
was exciting for several reasons. First, the pattern of stitching of the parallel alpha helices
represented a novel protein fold—something that is found less and less frequently as even
proteins without apparent sequence similarities are found to adopt similar folds from the subset
Nature has favored. Second, it raised the paradox of how a disc-shaped protein with calcium
binding sites confined to one side of the molecule could bind two membranes and form contacts
between them. Our favored resolution of this paradox, as mentioned above, is that annexins
bound to different membranes would have to interact with one another to cause membrane
aggregation,47 although unimolecular models have also been proposed by others100-102 involving
a hypothetical second membrane-binding face that has not been mapped. The annexin II tetramer
has apparently resolved this problem by orienting its two annexin cores in opposite directions.
Interestingly, annexin VI, which like the annexin II tetramer has two core domains, has the
flexibility to orient these domains either toward a single membrane, or in opposite directions
so that a single molecule could potentially bind two membranes.103
Annexins as Ion Channels
A third feature of immediate interest in the annexin V structure was the possibility that
ions could move through a hole in the center of the molecule, in coordination with the
rearrangement of certain salt linkages that stand in the way. This feature inspired a number of
structure/function analyses by Huber’s group involving site directed mutagenesis which support
the importance of certain channel-lining residues in playing a role in determining the observed
channel properties.104-106 Since the surface of the annexin was found to be highly polar, Huber
suggested the protein did not actually enter the membrane, but rested on the surface and by
virtue of its strong dipole moment blew a hole in the underlying lipids—a process of
electroporation.107,108
This “lightning bolt” model of ion permeation did not sit well with everyone. Harry
Haigler’s group in particular has presented an alternative model in which the annexin straightens
out turns between short alpha helices to construct transmembrane helices with nonpolar faces
that contact the hydrophobic portion of the lipid bilayer. The annexin is proposed to become
completely embedded in a transmembrane orientation.109 In vitro this transition requires
lowering the pH significantly, and this remains a troubling aspect of this hypothesis. Nonetheless,
the site-directed spin labeling studies he and his collaborators have completed do indicate
significant conformational changes occur in the structure of the protein. It will be important to
see if this new conformation can be visualized by X-ray diffraction or electron microscopy.
At this point there seem to be at least three models to explain the effect of annexins on ion
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membrane surface may create alterations in lipid organization, forming domain boundaries
that act as defects permitting ion permeation, not necessarily immediately at the site of the
protein. Second, (the Huber model) the annexin itself may provide a selective channel that sits
on the membrane surface and passes ions into a region of lipid disorganized by the strong
electric field underneath the protein. Third, (the Haigler model) the protein may refold to look
something like a classical integral membrane channel. To me, any of these mechanisms would
be of interest. However, the most important issue is whether the channel phenomenon occurs
biologically. Published studies to date have detailed annexin channel activity only in synthetic
bilayers of simple lipid compositions. Mammalian or yeast cells seem quite tolerant of the
overexpression of annexins, so the channel activity seems oddly silent in these heterologous
models.110 Annexin gene knockout experiments have indicated differences in calcium
homeostasis;111-114 perhaps this reflects loss of channel activity, but annexins can also influence
the activity of classical ion channels115,116 so the interpretation of these knockouts does not
seem simple. I believe the existence of these channels in cells is one of the most important issues
that needs to be resolved in the annexin field. Harking back to my own interest in exocytosis,
perhaps annexins assemble to form the initial openings at sites of membrane fusion, and it is
these assemblies that have properties manifested as channels in the in vitro experiments. On
the other hand, the hypothesis that cells are filled with high concentrations of occult channels
that can drift from place to place through the cytoplasm and promote ion movements across
membranes when needed is very provocative, and, indeed, I would say courageous.
Annexin Partners
Genomic sequencing has revealed that the annexin core domains are never incorporated
into the sequences of larger proteins. In this regard the annexins are different from EF hands or
C2 domains which are calcium-binding modules that may be incorporated into other proteins.
Many of the EF hand proteins, like calmodulin, consist of little more than EF hands. Nonetheless,
EF hands also appear occasionally as apparent regulatory domains in larger proteins, for example
in the calpains and the spectrins. On the other hand, the C2 domains, which biochemically
behave very much like annexins in their ability to bind and aggregate membranes in vitro,117
never appear as isolated proteins, but are only expressed as regulatory domains in larger proteins,
as first found in protein kinase C. In addition, the C2 domains are often found in pairs or
higher multiples, as in synaptotagmin, copine, or munc 13. This suggests they may act
cooperatively to enhance lipid binding affinity or to sense complex membrane compositions.
The annexins seem to function alone. This fundamental difference between the annexins and
the C2 domain might argue that the functional significance of the annexins is primarily associated
with their direct actions on membranes—bringing them together, organizing their lipids, or
transporting ions—and not with their ability to regulate the activities of other proteins.
However, annexins do interact with a number of other proteins. The marriage of annexins
to EF hand proteins is a consistent theme: Annexin II interacting with p11 (S100A10); annexin
I with S100C (S100A11),118 annexin XI with calcyclin,119 annexin VII with sorcin,91 and
annexin VI with S100A1 and S100B. 120 It is most likely that the purpose of these interactions
is to regulate the functions of the annexins, not the EF hand proteins, although transport of the
EF hand protein to a membrane so that it could move to another target is also a possibility.
Without exception, the EF hand proteins that bind annexins all form dimers, so it is tempting
to think that the EF hand proteins, by forming tetramers with annexin core domains, enhance
the ability of annexins to bind to two membranes simultaneously. This would seem to be
another validation of the hypothesis that the bivalent activity of annexins is physiologically
important.13 Reflections on Twenty-Five Years of Annexin Research
A few other proteins have been reported to bind annexins, such as plasminogen,8,9
tenascin,13 spectrin,37 actin,37,121 apolipoprotein A1122 and p120GAP.123 Even parts of annexins
can apparently interact in important ways with targets: N-terminal fragments of annexin I can
bind the formyl peptide receptor on neutrophils.124 This interaction may explain some of the
anti-inflammatory properties of this protein. The annexins might also interact with one another
to create assemblies that can organize lipid mixtures of complex compositions.125 Of course
annexins may also influence the activities of other proteins in a more indirect way—by organizing
lipids to create environments that activate or assemble other proteins. The presence of annexins
in “lipid rafts” may be a reflection of such a role.126-129
Annexins in Model Organisms
The presence of annexins in a number of model organisms should facilitate genetic and
other specialized approaches to understanding their functions. After spending years looking for
annexins in yeast,130 only to learn of their absence after the genome was sequenced, we turned
more of our efforts to the nematode C. elegans as a model system. There are four annexin genes
in the nematode, and we obtained evidence for expression of three of them.131 Nex-1 is expressed
at the highest levels and is present in many structures in the worm.132 Although we were unable
to obtain a transposon insertion mutant to study, possibly because of viability problems, the
localization of this annexin in certain tissues was very provocative in terms of possible annexin
functions. I had never even heard of the spermathecal valve of the nematode when Jan Redick,
the electron microscopist who worked with us on the localization studies, came to show me a
picture of an incredibly high density of immunogold particles adhering to a curious complex of
membranes. Through a remarkably unlikely event she had obtained a perfect cross section
through the spermathecal valve.
This structure, as it took me several days to learn, is a sphincter that separates the uterus
from the spermathecal chamber, where sperm wait for eggs to enter from the ovary. After
fertilization occurs in the spermathecal chamber the egg has to squeeze through the spermathecal
valve to enter the uterus. This valve is constructed from a syncytium of four cells that form a
donut-like structure. The hole in the middle, through which the egg must pass, is only one fifth
the diameter of the egg. Therefore, the cell must stretch open the hole fivefold. Since membranes
don’t stretch much, there is a lot of extra membrane folded up in the resting valve, like the folds
of an accordion. The annexin was found to be highly enriched on these membranous folds.132
Annexin antibodies can pass through the hole without binding the membranes, providing
evidence that the annexin is on the cytoplasmic sides of the membrane folds.131 This puts the
protein in a perfect position to fold up the membranes when the valve closes (presumably in
response to calcium entry) and then to release the membranes to allow unfolding when the
valve opens.
Prior to this time, and since, I have seen many images of the localization of annexins in
cells. Because the proteins are ubiquitous, the localization often is fairly diffuse with some
association with membranes. However, many things go on in the cytoplasm of cells and on
membranes, so these images are not often very compelling in terms of providing an explanation
of what the annexin is doing. However, in the highly specialized spermathecal valve, it doesn’t
seem to me there is very much going on except the folding and unfolding of this membrane
array. I find this very suggestive that the annexin is there to mediate these reversible membrane
contacts. To the extent that this activity may reflect annexin functions elsewhere, it suggests a
“chaperone” activity for annexins in mediating membrane interactions—very much as we
originally proposed in the case of our model for synexin function in exocytosis. I think this is a
nice example of how insight into broader biological functions might sometimes come from a
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I must confess to a lingering thought that this would also be a very convenient location for ion
channels to exist to allow calcium entry during closing of the valve. Whether the nex-1 annexin
also, or instead, functions as an ion channel in this location will be interesting to determine.
With the development of techniques to silence gene expression in the nematode by the
injection of inhibitory RNA, the nematode system should be approached again to determine
the physiological importance of all four annexins present. The classic genetic model Neurospora
also seems promising to look at; sequencing of the genome is now virtually complete and it
appears to encode only a single annexin.133 Several mouse knockouts have been completed,
and more are certainly in the pipeline.1 The annexin VI mouse knockout phenotype is fairly
subtle,1,112 apparently involving calcium homeostasis, which is reminiscent of the phenotype
of the Dictyostelium synexin knockout.111 The mouse annexin VII knockout phenotype is,
frustratingly, either subtle113 or lethal134 apparently depending upon the specific disruption
technique employed. It seems these whole animal experiments are difficult to interpret in terms
of molecular functions of annexins. The results are not as straightforward as one might hope
when embarking on this complex technology. Nonetheless, these experiments certainly must
continue as they provide an essential complement to biochemical and structural studies.
Annexin Applications
A serendipitous offshoot of the study of annexins has been the development of technical
applications of these proteins. Initially pharmaceutical applications were envisioned that reflected
their presumed in vivo roles as anti-inflammatory mediators or anticoagulants. More recently
the signature ability of these proteins to seek out negatively charged lipids with high specificity
has led to application as markers of apoptotic cells.12 This application has proven its utility in
the research laboratory, and may also have medical importance in the ability to monitor apoptosis
in vivo associated with chemotherapy of malignant cells and in allograft rejection.135,136 The
ability to identify activated platelets has application in localizing thromboses in whole body
imaging techniques as well as targeting clot-busting drugs to visible or occult thromboses.137,138
The medical significance of pathologies possibly related to annexin dysfunction continues to
gain recognition, and may lead to new pharmacological interventions based on modulation of
annexin activities.3
I have also speculated that the nex-1 annexin in the nematode spermathecal valve might
make an effective target for anthelmintic drugs. Genomic sequencing of pathogenic nematodes
has revealed the presence of nex-1 homologs in many of these parasites. Currently used
nematocides are effective lethal agents. However, often eggs survive in the environment after
treatment of adult worms, leading to re-infection of plant, livestock, or human hosts. If the
function of the annexin in the spermathecal valve could be compromised, the eggs might not
be fertilized before passage through the valve, or might be trapped and unable to enter the
uterus. This could provide the basis of a nematode contraceptive. A combination of such an
agent with a nematocide might enable comprehensive, long-lasting treatment of plant or animal
communities and human populations where nematodes are endemic.139
I also expect that the growing field of shrinking machines may take advantage of the
properties of annexins. I would not be surprised to see nanotechnologists use annexins as sensors
for calcium or lipid analogs and as transducers to move or organize layers of lipids or other
charged molecules in simple machines.
Conclusion: The Functions of Annexins
So, after twenty-five years of research on annexins, how can I now respond to the question
of what the functions of these ubiquitous proteins may be? First I would note that the annexins
are abundant proteins. Measurements typically indicate they may total one or two per cent of15 Reflections on Twenty-Five Years of Annexin Research
cell protein. A rough estimate would then suggest that if all these annexins tried to jump on a
membrane when calcium entered a cell, about one half of all the phospholipid surface facing
the cytoplasm would be covered by annexins. I could easily be off by a factor of two. Perhaps it
is all of the available surface. It therefore seems to me that any process that occurs on membranes
in stimulated cells must either involve the active participation of annexins or must involve
mechanisms to get the annexins out of the way. In any event, the annexins cannot be ignored.
As an integral component of the peripheral coat of a membrane they are as fundamental as any
other membrane component—say phosphatidylserine. We do not ask what the function of
phosphatidylserine may be, because to answer this we would have to refer to all membrane
functions.
Beyond this, I would probably shrug my shoulders and wave my hand in the direction of
the vast annexin prairie. From the Chapters of this book alone it must be clear that the prairie
is in full bloom. I’d suggest you pick your own bouquet.
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